REDHILL BIOPHARMA LTD. Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019
REDHILL BIOPHARMA LTD. (RDHL) reported Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 of $6277.89 per share for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-10.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 · last filed 2025-04-10
| Period end | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2024-12-31 | $6277.89 20-F · filed 2025-04-10 | |
| 2023-12-31 | $6560.75 20-F · filed 2025-04-10 | $262.43 20-F · filed 2024-04-08 |
| 2022-12-31 | $272.80 20-F · filed 2024-04-08 | $6.82 20-F · filed 2023-04-28 |
| 2021-12-31 | $8.02 20-F · filed 2023-04-28 | |
| 2020-12-31 | $9.65 20-F · filed 2022-03-17 | |
| 2019-12-31 | $10.30 20-F · filed 2021-03-18 | $1.03 20-F · filed 2020-03-04 |
| 2018-12-31 | $0.96 20-F · filed 2020-03-04 |